The CPACS 1a/1b is open label so results are available once first patient data is known although it may be in batches or as the company deems appropriate (unless adverse which should not be withheld). So if it starts later this year we may be lucky with readouts if trial approval and recruitment goes well, but more likely in 2025 for expectations and H1 would be good.
- Forums
- ASX - By Stock
- RAC
- CPACS: Research, Results, Market Comparisons, and Valuations
CPACS: Research, Results, Market Comparisons, and Valuations, page-75
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.61 |
Change
0.000(0.00%) |
Mkt cap ! $273.4M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 21870 | $1.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 289 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 21870 | 1.605 |
2 | 1817 | 1.580 |
1 | 20000 | 1.560 |
1 | 6000 | 1.500 |
1 | 4205 | 1.450 |
Price($) | Vol. | No. |
---|---|---|
1.600 | 289 | 1 |
1.605 | 631 | 1 |
1.640 | 12136 | 1 |
1.650 | 17920 | 3 |
1.690 | 585 | 1 |
Last trade - 09.58am 13/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online